David Andersen has represented a variety of companies, individuals, private equity funds and institutional clients in general corporate and securities matters, with an emphasis on the representation of emerging-growth high-technology and biotechnology companies. In this capacity, Mr. Andersen has assisted clients in structuring, developing and positioning numerous business enterprises for venture capital investment, growth through acquisitions and eventual sale or initial public offerings.

Mr. Andersen’s practice includes counseling clients in connection with issues related to initial formation and capitalization, public and private offerings of debt and equity securities, including venture capital financing, technology transactions, strategic alliances, recapitalizations and corporate restructurings, and joint ventures. Mr. Andersen regularly assists companies with the purchase and sale of stock or assets, mergers and other change of control transactions. In addition, Mr. Andersen has represented a number of public companies in diverse industries (including technology, healthcare, manufacturing, entertainment and lodging) in all aspects of securities reporting and compliance, and advises clients with respect to a wide range of corporate governance issues, equity incentive plans and related matters.